Deadline 2026-12-02Value 15.9M CZK
The buyer, Nemocnice Pardubického kraje, a.s., wants a supplier for ongoing deliveries of a medicine containing tildrakizumab, an ATC L04AC17 product. It is a single-lot open tender for supplies over 4 years.
Licensed pharmaceutical wholesalers or distributors able to supply prescription biologic medicines to Czech hospitals on a multi-year basis.
Léčivý přípravek ATC skupiny L04AC17 s účinnou látkou TILDRAKIZUMAB
Documents, contact details and the way to submit a bid are in the official notice.
Read the official notice and bid →Source: TED, © European Union (CC BY 4.0), and Find a Tender (UK, Open Government Licence v3.0). Summaries are written by AI and may contain mistakes: always check the official notice.
The buyer, a hospital operator in Pardubice, Czechia, wants a supplier for ongoing deliveries of the medicine risankizumab (ATC group L04AC18). The contract is a single lot and runs for 4 years.
The buyer, a hospital operator in Pardubice, wants a supplier for ongoing deliveries of a medicine containing the active substance Jopromid (ATC group V08AB05, an X-ray contrast agent). The contract is a single lot and runs for 4 years.
The buyer, Nemocnice Pardubického kraje, wants ongoing supplies of the medicine remdesivir (ATC group J05AB16) for its hospitals. This is a single-lot open tender for supplies. Deliveries are to run over a period of 4 years.
The buyer, a hospital operator in Pardubice, wants ongoing supplies of solvents, diluents and irrigation solutions for four years. The tender is split into eight lots: water for injection (four lots, numbered I to IV), sodium chloride (two lots, I and II) and rinsing solutions (two lots, I and II).
The buyer, a hospital in Prague, wants repeated supplies of biologic medicines for its patients. The contract is split into 7 lots, one per product: pembrolizumab, ofatumumab, ocrelizumab, brentuximab vedotin, rituximab, obinutuzumab and denosumab. Bidders may submit a separate offer for each lot.
MorningTenders